IM Cannabis (IMCC) EBITDA Margin Growth (3y) (2023 - 2026)
IM Cannabis (IMCC) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 537,472.00 | -631,498.17 | 1.09 Mn | -4,081.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,081.00 |
| Mar 31, 2026 | -4,818.00 |
| Dec 31, 2025 | 30,562.00 |
| Sep 30, 2025 | -6,898.00 |
| Jun 30, 2025 | -4,703.00 |
| Mar 31, 2025 | -8,257.00 |
| Dec 31, 2024 | 3,871.00 |
| Sep 30, 2024 | 8,948.00 |
| Jun 30, 2024 | 7,699.00 |
| Mar 31, 2024 | -2,722.00 |
| Dec 31, 2023 | -6,060.00 |
| Sep 30, 2023 | 2,965.00 |
| Jun 30, 2023 | 8,926.00 |
| Mar 31, 2023 | -9,531.00 |